MedPath

Multicenter prospective observational study on the effectiveness of hypofractionated palliative radiotherapy for advanced head and neck squamous cell carcinoma (JROSG 18-2)

Not Applicable
Conditions
Advanced head and neck squamous cell carcinoma
Registration Number
JPRN-UMIN000039971
Lead Sponsor
Japanese Radiation Oncology Study Group (JROSG)
Brief Summary

Analysis in progress

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up continuing
Sex
All
Target Recruitment
50
Inclusion Criteria

Not provided

Exclusion Criteria

1) Patients with previous radiotherapy on regions that overlap with the irradiated volume. 2) Women who are pregnant, breastfeeding or may be pregnant. 3) Patients whom the attending physician deems unsuitable for participation in this study.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Completion rate for three cycles.
Secondary Outcome Measures
NameTimeMethod
Tumor response assessment based on imaging findings and physical examinations, overall survival, progression-free survival, QOL score, adverse events, additional treatment.
© Copyright 2025. All Rights Reserved by MedPath